gene therapy - search results

Dr Gerry Morrow shares his thoughts on the rare, progressive neurodegenerative illness, Huntington’s disease (HD).

In this interview, Professor Dr Martin Flück at the Laboratory for Muscle Plasticity at Balgrist University Hospital explains his fascinating research around musculoskeletal function, including the post-operation recovery of patients that have undergone surgery due to the rupture of a rotator cuff tendon.

Chief Executive of the Huntington’s Disease Association, Cath Stanley shares the latest updates on Huntington’s research from the 2018 conference.

Some of the priorities for supporting people with muscle-wasting conditions and their families are explored here by Open Access Government

To mark its 50-year anniversary, the National Eye Institute (NEI) takes stock of its progress in advancing vision research and developing new therapies to treat blinding diseases

Chief Executive for Action on Hearing Loss, Mark Atkinson charts the priorities for research into deafness, hearing loss and tinnitus towards a cure

Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)

Leora Fox, Jennifer Simpson and George Yohrling from the Huntington’s Disease Society of America explore the sources of funding in the development of therapies for Huntington’s disease (HD).

What will the future of medicine look like? A new virtual reality experience from the Association of the British Pharmaceutical Industry explores futuristic treatments and technologies like inhalable nanobots and 3D printed medicine patches

CEO of the BioIndustry Association (BIA), Steve Bates explores how the UK government is supporting biotech in order to create innovative medicines

Director of Research Support Dr Ana M Terres notes the importance of health research and the strides being achieved by researchers at Dublin City University

Food, chemical and industrial sectors are challenged with the growing population, increasing longevity and quality of life. In consequence, the demand for fossils energy sources, agricultural land and drinking water what will lead to irreversible changes in climate with unpredictable consequences. A recent declaration of G7 leaders that in...

Associate Professor Michela Alessandra Denti, Principal Investigator of the Laboratory of RNA Biology and Biotechnology at the Centre for Integrative Biology of the University of Trento, discusses how modulation of RNA splicing can represent a cure for inherited diseases RNA impacts nearly every aspect of gene expression and it is now clear...

Launched with an investment of €18 million, the UCD Charles Institute for Translational Dermatology is the first academic institute devoted to translational dermatology in Ireland and Europe. The Institute’s vision is to become a world leader in translational dermatology research, supporting optimal patient care in Ireland, and to establish...

From stem cell biology to tissue mending In the last 25 years, tremendous advances have been made in the identification and generation of stem cells (SC) from diverse organisms, generating a wealth of knowledge in various fields from embryology to development. SC not only have the ability to differentiate into...

AI is set to transform accessibility and inclusion in the public sector, creating new ways to remove barriers for people with disabilities.

A biomarker is a measurable substance, typically a chemical or biomolecule (protein, lipid, nucleic acid), found in biological samples that is indicative of a normal or abnormal condition of a living organism. But how can biomarkers be used in deciphering human health impacts of environmental contaminants?

Here Open Access Government explore a testimonial from a patient who received a “wonder” therapy for his knee osteoarthritis (OA).

In a new effort to revolutionise treatment for eye injuries and disorders, a team of researchers from the University of Liverpool have secured £2.1 million in funding.

Curbs on animal testing mean human tissues derived from induced pluripotent stem cells offer a promising platform in discovering novel treatments for cardiac ailments.